@article{29393, keywords = {Vaccines, Synthetic, Vaccines, Contraceptive, Vaccination, Recombinant Fusion Proteins, Pregnancy, Mice, Inbred BALB C, Mice, Humans, Female, Escherichia coli Proteins, Enterotoxins, DNA, Contraception, Immunologic, Chorionic Gonadotropin, beta Subunit, Human, Bacterial Toxins, Antibody Formation, Antibodies, Animals}, author = {Nand KN and Gupta JC and Panda A and Jain S and Talwar G}, title = {Priming with DNA Enhances Considerably the Immunogenicity of hCG β-LTB Vaccine.}, abstract = {

PROBLEM: Necessity to elicit antibody response above the protective threshold titres by sexually active women immunized to prevent pregnancy.

METHOD OF STUDY: Recombinant hCGβ-LTB vaccine expressed as both DNA and protein. Balb C mice employed for testing immunogenicity.

RESULTS: Necessity to give three primary injections of the vaccine to elicit proper antibody response. Immunization twice with DNA form of the vaccine at fortnightly interval followed by the protein elicits a distinctly higher antibody response than proteinic vaccine alone. Antibodies generated are bio-effective against hCG.

CONCLUSION: Immunization with the DNA form of the recombinant hCGβ-LTB vaccine twice at fortnightly interval followed by the proteinic form of the vaccine induces distinctly higher antibody response.

}, year = {2015}, journal = {American journal of reproductive immunology (New York, N.Y. : 1989)}, volume = {74}, pages = {302-8}, issn = {1600-0897}, doi = {10.1111/aji.12388}, language = {eng}, }